Azenta, Inc. (NasdaqGS: AZTA)
Health Care · Life Sciences Tools & Services · US
$37.20
-1.38% today · +18.9% 1Y
Azenta, Inc. (NasdaqGS: AZTA) operates in the Life Sciences Tools & Services industry within the Health Care sector. The company is valued at $1.65B and employs 2,900 people.
Over the last twelve months the share price has gained 18.9%, trading between 15.93 and 46.41.
Tweenvest scores Azenta, Inc. across four factors: quality 68/100, value 56/100, growth 54/100. Its strongest factor is quality.
AZTA price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $1.65B
- Revenue (TTM)
- $613.81M
- P/E
- —
- EPS
- -2.70
- Dividend yield
- —
- Beta (5Y)
- 1.52
- 52-week high
- $46.41
- 52-week low
- $15.93
- Avg volume (3M)
- —
- Shares outstanding
- 43.81M
- Employees
- 2,900
- Next earnings
- —
About Azenta, Inc.
Azenta, Inc. is a global leader specializing in advanced solutions for the discovery, handling, and preservation of life science samples. The company's operations span across North America, Europe, Asia Pacific (including China), and other international markets. Its business is structured into two main reportable segments: Life Sciences Products and Life Sciences Services. The Life Sciences Products division supplies sophisticated automated systems for the cold storage of chemical compounds and biological specimens. This segment also provides crucial equipment for sample preparation and manipulation, along with various consumables and specialized instruments that empower customers to effectively manage samples throughout their entire research and development workflows. Conversely, the Life Sciences Services segment offers a comprehensive suite of programs for sample management, integrated cold chain logistics, cutting-edge informatics, and a range of sample-centric laboratory services. These offerings are vital for propelling scientific research and accelerating drug development. Key services include secure sample banking, advanced genomic sequencing, gene synthesis, laboratory processing, detailed laboratory analysis, biospecimen acquisition, and other essential support functions. Azenta caters to a diverse client base within the life sciences sector, encompassing pharmaceutical companies, biotechnology firms, biorepositories, and academic or private research institutions. Established in 1978, the company, originally known as Brooks Automation, Inc., officially became Azenta, Inc. in December 2021. Its corporate headquarters are located in Chelmsford, Massachusetts.
- ISIN
- US1143401024
- Founded
- 1978
- Listed since
- Feb 2, 1995
- Exchange
- Nasdaq Global Select
- Currency
- USD
Other Life Sciences Tools & Services companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Suzhou Sepax Technologies Co., Ltd.SHSE: 688758 | $1.81B | CN¥29.06 | -3.55% |
| PolyPeptide Group AGSWX: PPGN | $1.74B | CHF43.95 | +0.23% |
| OneSource Specialty Pharma LimitedNSEI: ONESOURCE | $1.73B | Rs1,461.30 | -3.10% |
| Personalis, Inc.NasdaqGM: PSNL | $1.71B | $15.87 | -0.81% |
| Peptron, Inc.KOSDAQ: A087010 | $1.59B | ₩91,500.00 | -29.34% |
| ChemoMetec A/SCPSE: CHEMM | $1.51B | Dkr587.50 | +0.17% |
| Indegene LimitedNSEI: INDGN | $1.44B | Rs580.10 | -2.26% |
| Syngene International LimitedNSEI: SYNGENE | $1.43B | Rs347.40 | -3.85% |
Figures last refreshed Oct 11, 2026.